Tretinoin prior authorization criteria (Kentucky Medicaid)
Customize your policy alerts
Sign up for all medimpact policy alerts
Know when medimpact releases new policies or updates existing guidance.
Monitor payer policy activity
Defines new prior authorization clinical criteria for tretinoin formulations for Kentucky Medicaid (Fee-for-Service and MCO) effective June 1, 2026; affects pharmacy providers, prescribers, and beneficiaries covered by Kentucky Medicaid.
Tretinoin cream, tretinoin microsphere gel, and clindamycin/tretinoin gel are subject to prior authorization beginning 06/01/2026.
Approval duration set to 1 year when criteria met.
Clinical criteria require diagnosis of acne vulgaris and prescriber attestation that the medication is not being used solely for cosmetic purposes.
Coverage Criteria
Initial authorization
Covered when ALL of the following are met:
Approval duration: 1 year when criteria are met.
Use solely for cosmetic purposes is excluded from coverage under these criteria. Examples of cosmetic indications that are not covered include photoaging, wrinkling, hyperpigmentation, melasma, roughness of skin, or sun damage.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.